Selected research
Industry Research
Cell therapy platform Industry Research Report 2026
Market perspective
The global Cell therapy platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cell therapy platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cell therapy platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cell therapy platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cell therapy platform include Novartis, Gilead Sciences, Regeneron Pharmaceuticals, Takeda Pharmaceuticals, Roche, Bluebird Bio, Cellectis, Sangamo Therapeutics and Fate Therapeutics. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cell therapy platform market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cell therapy platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cell therapy platform Market by Company
Novartis
Gilead Sciences
Regeneron Pharmaceuticals
Takeda Pharmaceuticals
Roche
Bluebird Bio
Cellectis
Sangamo Therapeutics
Fate Therapeutics
Cell therapy platform Segment by Type
Autologous Cell Therapy Platform
Allogeneic Cell Therapy Platform
Others
Cell therapy platform Segment by Application
General Hospital
Specialized Hospital
Others
Cell therapy platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell therapy platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell therapy platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell therapy platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cell therapy platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Autologous Cell Therapy Platform
- Allogeneic Cell Therapy Platform
- Others
Applications
- General Hospital
- Specialized Hospital
- Others
Companies covered
- Novartis
- Gilead Sciences
- Regeneron Pharmaceuticals
- Takeda Pharmaceuticals
- Roche
- Bluebird Bio
- Cellectis
- Sangamo Therapeutics
- Fate Therapeutics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cell therapy platform by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Autologous Cell Therapy Platform
- 2.2.3 Allogeneic Cell Therapy Platform
- 2.2.4 Others
- 2.3 Cell therapy platform by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 General Hospital
- 2.3.3 Specialized Hospital
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Cell therapy platform Breakdown Data by Type
- 3.1 Global Cell therapy platform Historic Market Size by Type (2021-2026)
- 3.2 Global Cell therapy platform Forecasted Market Size by Type (2027-2032)
4 Cell therapy platform Breakdown Data by Application
- 4.1 Global Cell therapy platform Historic Market Size by Application (2021-2026)
- 4.2 Global Cell therapy platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cell therapy platform Market Perspective (2021-2032)
- 5.2 Global Cell therapy platform Growth Trends by Region
- 5.2.1 Global Cell therapy platform Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cell therapy platform Historic Market Size by Region (2021-2026)
- 5.2.3 Cell therapy platform Forecasted Market Size by Region (2027-2032)
- 5.3 Cell therapy platform Market Dynamics
- 5.3.1 Cell therapy platform Industry Trends
- 5.3.2 Cell therapy platform Market Drivers
- 5.3.3 Cell therapy platform Market Challenges
- 5.3.4 Cell therapy platform Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cell therapy platform Players by Revenue
- 6.1.1 Global Top Cell therapy platform Players by Revenue (2021-2026)
- 6.1.2 Global Cell therapy platform Revenue Market Share by Players (2021-2026)
- 6.2 Global Cell therapy platform Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cell therapy platform Head Office and Area Served
- 6.4 Global Cell therapy platform Players, Product Type & Application
- 6.5 Global Cell therapy platform Manufacturers Established Date
- 6.6 Global Cell therapy platform Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cell therapy platform Market Size (2021-2032)
- 7.2 North America Cell therapy platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cell therapy platform Market Size by Country (2021-2026)
- 7.4 North America Cell therapy platform Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cell therapy platform Market Size (2021-2032)
- 8.2 Europe Cell therapy platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cell therapy platform Market Size by Country (2021-2026)
- 8.4 Europe Cell therapy platform Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cell therapy platform Market Size (2021-2032)
- 9.2 Asia-Pacific Cell therapy platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cell therapy platform Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cell therapy platform Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cell therapy platform Market Size (2021-2032)
- 10.2 South America Cell therapy platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cell therapy platform Market Size by Country (2021-2026)
- 10.4 South America Cell therapy platform Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cell therapy platform Market Size (2021-2032)
- 11.2 Middle East & Africa Cell therapy platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cell therapy platform Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cell therapy platform Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Novartis
- 12.1.1 Novartis Company Information
- 12.1.2 Novartis Business Overview
- 12.1.3 Novartis Revenue in Cell therapy platform Business (2021-2026)
- 12.1.4 Novartis Cell therapy platform Product Portfolio
- 12.1.5 Novartis Recent Developments
- 12.2 Gilead Sciences
- 12.2.1 Gilead Sciences Company Information
- 12.2.2 Gilead Sciences Business Overview
- 12.2.3 Gilead Sciences Revenue in Cell therapy platform Business (2021-2026)
- 12.2.4 Gilead Sciences Cell therapy platform Product Portfolio
- 12.2.5 Gilead Sciences Recent Developments
- 12.3 Regeneron Pharmaceuticals
- 12.3.1 Regeneron Pharmaceuticals Company Information
- 12.3.2 Regeneron Pharmaceuticals Business Overview
- 12.3.3 Regeneron Pharmaceuticals Revenue in Cell therapy platform Business (2021-2026)
- 12.3.4 Regeneron Pharmaceuticals Cell therapy platform Product Portfolio
- 12.3.5 Regeneron Pharmaceuticals Recent Developments
- 12.4 Takeda Pharmaceuticals
- 12.4.1 Takeda Pharmaceuticals Company Information
- 12.4.2 Takeda Pharmaceuticals Business Overview
- 12.4.3 Takeda Pharmaceuticals Revenue in Cell therapy platform Business (2021-2026)
- 12.4.4 Takeda Pharmaceuticals Cell therapy platform Product Portfolio
- 12.4.5 Takeda Pharmaceuticals Recent Developments
- 12.5 Roche
- 12.5.1 Roche Company Information
- 12.5.2 Roche Business Overview
- 12.5.3 Roche Revenue in Cell therapy platform Business (2021-2026)
- 12.5.4 Roche Cell therapy platform Product Portfolio
- 12.5.5 Roche Recent Developments
- 12.6 Bluebird Bio
- 12.6.1 Bluebird Bio Company Information
- 12.6.2 Bluebird Bio Business Overview
- 12.6.3 Bluebird Bio Revenue in Cell therapy platform Business (2021-2026)
- 12.6.4 Bluebird Bio Cell therapy platform Product Portfolio
- 12.6.5 Bluebird Bio Recent Developments
- 12.7 Cellectis
- 12.7.1 Cellectis Company Information
- 12.7.2 Cellectis Business Overview
- 12.7.3 Cellectis Revenue in Cell therapy platform Business (2021-2026)
- 12.7.4 Cellectis Cell therapy platform Product Portfolio
- 12.7.5 Cellectis Recent Developments
- 12.8 Sangamo Therapeutics
- 12.8.1 Sangamo Therapeutics Company Information
- 12.8.2 Sangamo Therapeutics Business Overview
- 12.8.3 Sangamo Therapeutics Revenue in Cell therapy platform Business (2021-2026)
- 12.8.4 Sangamo Therapeutics Cell therapy platform Product Portfolio
- 12.8.5 Sangamo Therapeutics Recent Developments
- 12.9 Fate Therapeutics
- 12.9.1 Fate Therapeutics Company Information
- 12.9.2 Fate Therapeutics Business Overview
- 12.9.3 Fate Therapeutics Revenue in Cell therapy platform Business (2021-2026)
- 12.9.4 Fate Therapeutics Cell therapy platform Product Portfolio
- 12.9.5 Fate Therapeutics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst